Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 GBX | +3.12% |
|
-4.35% | -22.35% |
05-23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
05-23 | Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.35% | 3.85M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.76% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- FAB Stock
- News Fusion Antibodies plc
- Fusion Antibodies Receives R&D Tax Credit from UK Government